FDA
Pilocarpine Hydrochloride
The FDA lists this product in 22 strengths and forms.
Indications
Pilocarpine hydrochloride ophthalmic solution is indicated for the: Pilocarpine hydrochloride ophthalmic solution is a muscarinic cholinergic agonist indicated for: The reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. (1.1) The management of acute angle-closure glaucoma. (1.2) The prevention of postoperative elevated IOP associated with laser surgery. (1.3) The induction of miosis.
(1.4)
1.1 Reduction of Elevated Intraocular Pressure (IOP) in Patients with Open-Angle Glaucoma or Ocular Hypertension
1.2 Management of Acute Angle-Closure Glaucoma
1.3 Prevention of Postoperative Elevated IOP Associated with Laser Surgery
1.4 Induction of Miosis
Contraindications
None. None.
Warnings and precautions
Poor illumination: Exercise caution in night driving and other hazardous occupations in poor illumination. (5.1) Pre-existing retinal disease: Rare cases of retinal detachment have been reported; a thorough examination of the retina including funduscopy is advised in all patients prior to the initiation of therapy. (5.2) Iritis: Caution is advised in patients with iritis. (5.3) Congenital glaucoma: Caution is advised in pediatric patients with primary congenital glaucoma for control of IOP as cases of a paradoxical increase in IOP have been reported.
(5.4)
5.1Poor Illumination
Patients should be advised to exercise caution in night driving and other hazardous occupations in poor illumination. In addition, miotics may cause accommodative spasm. Patients should be advised not to drive or use machinery if vision is not clear.